| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/28/2000 | CN1257704A Submicro emulsion based on sugar fatty ester and sugar fatty ether, and use thereof |
| 06/28/2000 | CN1053836C Wound and sore plaster and preparing process thereof |
| 06/28/2000 | CN1053830C Method for preparation of drug for curing cataract of livestock |
| 06/28/2000 | CN1053826C Tonic hypoglycemic capsule and preparing process thereof |
| 06/28/2000 | CN1053825C 'Wuling' hepatitis C powder |
| 06/28/2000 | CN1053824C Exterior-use traditional Chinese medicine ointment and its preparing method |
| 06/28/2000 | CN1053823C Health-care oral liquor for preventing cold and raising immunity |
| 06/28/2000 | CN1053817C Acanthopanax root extract, its producing process, and injection contg. same and freeze-dried powder contg. same for injection |
| 06/28/2000 | CN1053813C Health-care medicinal core and its preparation method |
| 06/28/2000 | CN1053808C Nivadipine controlled-release agent |
| 06/28/2000 | CN1053807C Vitamin E drop |
| 06/27/2000 | USRE36754 Devices using silicone pressure sensitive adhesives containing organic wax |
| 06/27/2000 | US6080783 Applying the zinc gluconate and a carrier in preferred ratio to the nose epithelial membrane and maintaining the medicine in contact with nose membrane for atleast 10 minutes to cure common cold in human |
| 06/27/2000 | US6080765 Pharmaceutical composition |
| 06/27/2000 | US6080762 Having the patient inhale an aerosolized amount of raloxifene (hydrochloride) through the patient's mouth or nose into the lungs; aerosols; postmenopausal syndrome; osteoporosis |
| 06/27/2000 | US6080744 Topical antifungal treatment |
| 06/27/2000 | US6080739 Colchicine-skeleton compounds, their use as medicaments and compositions containing them |
| 06/27/2000 | US6080731 Dinucleoside-5', 5'-pyrophosphates administered to treat HIV |
| 06/27/2000 | US6080728 Inhibiting tumor growth |
| 06/27/2000 | US6080721 Pulmonary delivery of active fragments of parathyroid hormone |
| 06/27/2000 | US6080538 Plasma like solution and methods of use |
| 06/27/2000 | US6080429 Emulsifying an active agent or an aqueous solution by adding to a solution of polymer/solvent; extracting excess solvent with an aqueous solution to produce microspheres; dehydrating drying in a fluidized bed; high speed; noncracking |
| 06/27/2000 | US6080428 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 06/27/2000 | US6080427 Uncoated compressed tablets for oral administration by swallowing, chewing or drinking in water; containing microcrystalline cellulose, guar gum; polyvinylpyrrolidone, silica sol, dibasic calcium phoshate and mannitol |
| 06/27/2000 | US6080426 Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process |
| 06/27/2000 | US6080422 Administering a lipid acceptor selected from the group consisting of large liposomes comprised of phospholipids substantially free of sterol and small acceptors. prevention of restenosis during revascularization |
| 06/27/2000 | US6080421 Transdermal therapeutic system identified without printing inks |
| 06/27/2000 | US6080418 Suspensions of microcapsules containing biologically active ingredients and adhesive microspheres |
| 06/27/2000 | US6080416 A hydroalcohol mixture of stearoxytrimethylsilane, cyclomethicone, cetyl lactate and a c1-15 alkyl lactate and ethyh, isopropyl and/or propyl alcohol and/or water; nontacky; moisturizing; protective coatings; skins |
| 06/27/2000 | US6080412 Pharmaceutical microencapsulation |
| 06/27/2000 | US6080397 Infusion or surgical rinse colloidal solutions of polyvinylpyrrolidone (pvp) of given molecular weight; free of impurities and high molecular weight pvp, and having low: amine content, peroxide, and solvent; nonallergenic |
| 06/27/2000 | US6080396 Anthracycline compound derivative and pharmaceutical preparation containing the same |
| 06/27/2000 | US6080395 Method and composition for topical treatment of damaged tissue using histamine as active ingredient |
| 06/27/2000 | US6079416 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis |
| 06/27/2000 | CA2150244C Chlorofluoroether compositions and preparation thereof |
| 06/27/2000 | CA2030581C Pancreatin preparations |
| 06/27/2000 | CA2024505C Dosage form for delivering soluble or insoluble drugs |
| 06/24/2000 | CA2296193A1 Powdered dextrose and procedure for preparing it |
| 06/23/2000 | CA2257001A1 Method and formulations for prevention of infection of mucosae and/or skin and development of a vaginal/ano-rectal applicator for the delivery of topical formulations |
| 06/22/2000 | WO2000036352A1 Flowable, ready-to-be-compressed medical intermediate products for tablets, pellets and dragees and method for producing the same |
| 06/22/2000 | WO2000036201A2 Magnetized pre-wound sideless bobbins |
| 06/22/2000 | WO2000036153A1 Method of drying a lactulose solution |
| 06/22/2000 | WO2000036113A2 Extending graft survival by heme oxygenase-i expression induced immunomodulation |
| 06/22/2000 | WO2000035990A1 Process for producing polymer |
| 06/22/2000 | WO2000035909A1 4-aryloxindoles as inhibitors of jnk protein kinases |
| 06/22/2000 | WO2000035907A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
| 06/22/2000 | WO2000035891A1 Morpholinone and morpholine derivatives and uses thereof |
| 06/22/2000 | WO2000035858A1 Phenylglycine derivatives |
| 06/22/2000 | WO2000035754A1 Method and system with electronic control devices for blending of chinese herbal medicine |
| 06/22/2000 | WO2000035571A1 Microemulsions containing water and hydrofluoroethers |
| 06/22/2000 | WO2000035486A1 Soluble compositions of toremifene |
| 06/22/2000 | WO2000035485A1 Soluble compositions of triphenylethylene antiestrogens |
| 06/22/2000 | WO2000035484A2 Methods and compositions for decreasing allergic reactions to surface allergens |
| 06/22/2000 | WO2000035461A1 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 06/22/2000 | WO2000035460A2 Pharmaceutical formulations |
| 06/22/2000 | WO2000035459A1 New solid metriphonate formulations |
| 06/22/2000 | WO2000035458A1 Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide |
| 06/22/2000 | WO2000035457A1 Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males |
| 06/22/2000 | WO2000035456A1 Transdermal delivery system containing buprenorphine |
| 06/22/2000 | WO2000035450A1 Controlled/modified release oral methylphenidate formulations |
| 06/22/2000 | WO2000035448A1 New pharmaceutical formulation |
| 06/22/2000 | WO2000035445A1 Doramectin formulations |
| 06/22/2000 | WO2000035441A2 Pharmaceutical aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| 06/22/2000 | WO2000035439A1 The process for manufacturing formulation of topical beta blockers with improved efficacy |
| 06/22/2000 | WO2000035438A1 Compositions for increasing carotenoid levels |
| 06/22/2000 | WO2000035437A2 Improving mental performance by increasing brain insulin sensitivity |
| 06/22/2000 | WO2000035434A2 Compositions and methods for the treatment of anorectal disorders |
| 06/22/2000 | WO2000035426A2 Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
| 06/22/2000 | WO2000035425A1 STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR |
| 06/22/2000 | WO2000035424A1 Polyethylene glycol coating for electrostatic dry deposition of pharmaceuticals |
| 06/22/2000 | WO2000035423A1 Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 06/22/2000 | WO2000035422A2 Method of administering a compound to multi-drug resistant cells |
| 06/22/2000 | WO2000035421A2 Integrative protein-dna cochleate formulations and methods for transforming cells |
| 06/22/2000 | WO2000035420A2 Stable surgical irrigating solutions |
| 06/22/2000 | WO2000035419A2 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
| 06/22/2000 | WO2000035418A2 Chewable drug delivery system |
| 06/22/2000 | WO2000035417A1 Pharmaceutical preparation for inhalation of an opioid |
| 06/22/2000 | WO2000035408A2 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 06/22/2000 | WO2000035357A1 Methods and apparatus for enhancement of transdermal transport |
| 06/22/2000 | WO2000035298A1 Chewing gum containing medicament active agents |
| 06/22/2000 | WO2000035296A1 Improved release of medicament active agents from a chewing gum coating |
| 06/22/2000 | WO2000035295A1 Controlling release of active agents from a chewing gum coating |
| 06/22/2000 | WO2000035289A1 Hydrogen peroxide disinfectant with increased activity |
| 06/22/2000 | WO2000035280A1 Exo-r-mecamylamine formulation and use in treatment |
| 06/22/2000 | WO2000035279A1 Exo-s-mecamylamine formulation and use in treatment |
| 06/22/2000 | WO2000021504A8 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
| 06/22/2000 | WO2000012060A8 Electrically controlled transport of charged penetrants across barriers |
| 06/22/2000 | WO2000010628A3 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| 06/22/2000 | WO2000008004A8 Particle-forming compositions containing fused pyrrolocarbazoles |
| 06/22/2000 | WO2000004954A3 Novel urokinase inhibitors |
| 06/22/2000 | WO1999038504A8 Pharmaceutical uses of optically pure (-)-bupropion |
| 06/22/2000 | CA2393442A1 Exo-r-mecamylamine formulation and use in treatment |
| 06/22/2000 | CA2355936A1 A flowable drug precursor product and a process for preparing same |
| 06/22/2000 | CA2355777A1 Controlling release of active agents from a chewing gum coating |
| 06/22/2000 | CA2355775A1 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 06/22/2000 | CA2355650A1 Methods and compositions for decreasing allergic reactions to surface allergens |
| 06/22/2000 | CA2355645A1 Increasing brain glucose utilization |
| 06/22/2000 | CA2355202A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
| 06/22/2000 | CA2355201A1 Morpholinone and morpholine derivatives and uses thereof |
| 06/22/2000 | CA2355184A1 Methods and apparatus for enhancement of transdermal transport |